Anticancer efficacy of biosynthesized silver nanoparticles loaded with recombinant truncated parasporin-2 protein
Issued Date
2024-12-01
Resource Type
eISSN
20452322
Scopus ID
2-s2.0-85197673543
Journal Title
Scientific Reports
Volume
14
Issue
1
Rights Holder(s)
SCOPUS
Bibliographic Citation
Scientific Reports Vol.14 No.1 (2024)
Suggested Citation
Srisaisap M., Boonserm P. Anticancer efficacy of biosynthesized silver nanoparticles loaded with recombinant truncated parasporin-2 protein. Scientific Reports Vol.14 No.1 (2024). doi:10.1038/s41598-024-66650-5 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/99661
Title
Anticancer efficacy of biosynthesized silver nanoparticles loaded with recombinant truncated parasporin-2 protein
Author(s)
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Bacterial toxins have received a great deal of attention in the development of cancer treatments. Parasporin-2 (PS2Aa1 or Mpp46Aa1) is a Bacillus thuringiensis parasporal protein that preferentially destroys human cancer cells while not harming normal cells, making it a promising anticancer treatment. With the efficient development and sustainable silver nanoparticles (AgNPs) synthesis technology, the biomedical use of AgNPs has expanded. This study presents the development of a novel nanotoxin composed of biosynthesized silver nanoparticles loaded with the N-terminal truncated PS2Aa1 toxin. MOEAgNPs were synthesized using a biological method, with Moringa oleifera leaf extract and maltose serving as reducing and capping agents. The phytochemicals present in M. oleifera leaf extract were identified by GC–MS analysis. MOEAgNPs were loaded with N-terminal truncated PS2Aa1 fused with maltose-binding protein (MBP-tPS2) to formulate PS2-MOEAgNPs. The PS2-MOEAgNPs were evaluated for size, stability, toxin loading efficacy, and cytotoxicity. PS2-MOEAgNPs demonstrated dose-dependent cytotoxicity against the T-cell leukemia MOLT-4 and Jurkat cell lines but had little effect on the Hs68 fibroblast or normal cell line. Altogether, the current study provides robust evidence that PS2-MOEAgNPs can efficiently inhibit the proliferation of T-cell leukemia cells, thereby suggesting their potential as an alternative to traditional anticancer treatments.